Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Here are three fantastic biotech stocks harnessing the power of AI that could make a great addition to your portfolio. The ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target ...

Robert F. Kennedy Jr’s message of eliminating toxins and investigating public health agencies has resonated among a key group ...

United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

OpenAI has made headlines on more than one occasion over the last few months. Firstly, it was due to the sudden emergence of ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...

MicroStrategy, the business intelligence firm and Bitcoin treasury company co-founded by Michael Saylor has rebranded to ...

Beta Bionics (BBNX) leads innovation in the diabetes treatment market with its groundbreaking iLet Bionic Pancreas technology ...

MicroStrategy Inc. (NASDAQ:MSTR) has officially rebranded as Strategy, reflecting its sharpened focus on Bitcoin ...